Early studies suggest an experimental Alzheimer's drug attacks free-floating bits of a protein called beta amyloid, a sign the drug may fight what some researchers consider to be the disease's chief culprit.
via news.yahoo.com
Here is some more encouraging news for Alzheimer's patients.
No comments:
Post a Comment